Related Experiment Video

Updated: Jun 21, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
12:27

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

Reversibility of acute intermediate phase bilirubin encephalopathy

Thor Willy Ruud Hansen1, Lutz Nietsch, Elisabeth Norman

  • 1Neonatal Intensive Care Unit, Division of Paediatrics, Oslo University Hospital, Oslo, Norway. t.w.r.hansen@medisin.uio.no

Acta Paediatrica (Oslo, Norway : 1992)
|July 9, 2009
PubMed

Insights

Acute bilirubin encephalopathy in infants may be reversible with prompt, aggressive treatment. Aggressive intervention in extremely jaundiced infants with neurological symptoms can lead to normal neurological outcomes.

Area of Science:

  • Neonatal Medicine
  • Neuroscience
  • Pediatrics

Background:

  • Bilirubin encephalopathy, a serious condition in newborns, can lead to severe neurological impairment.
  • Intermediate to advanced stages of acute bilirubin encephalopathy pose significant challenges in management and prognosis.

Observation:

  • This study examined six infants with extreme jaundice and symptoms of intermediate to advanced acute bilirubin encephalopathy.
  • Brain magnetic resonance imaging in two patients revealed increased signals in the globus pallidus, a characteristic finding.

Findings:

  • All six infants received aggressive treatment for their condition.
  • Following treatment, all infants demonstrated a complete recovery, with no neurological deficits observed on follow-up.

Implications:

  • These findings suggest that acute bilirubin encephalopathy, even in advanced stages, may be reversible.
  • The results underscore the critical importance of rapid and aggressive intervention for infants presenting with severe jaundice and neurological symptoms to prevent long-term disability.
Abstract

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...